We are live on ! Find out more
RXST icon

RxSight

40 hedge funds and large institutions have $75M invested in RxSight in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 7

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

3% more funds holding

Funds holding: 3940 (+1)

4.63% less ownership

Funds ownership: 29%24.37% (-4.6%)

25% less capital invested

Capital invested by funds: $100M → $75M (-$25.4M)

Holders
40
Holders Change
+1
Holders Change %
+2.56%
% of All Funds
0.62%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
19
Reduced
7
Closed
4
Calls
Puts
Net Calls
Net Calls Change

RXST Hedge Fund Activity: Q4 2021 in Review

40 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q4 2021, worth a combined $75M — down 25% from $100M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new RXST positions and 4 closed out — a net gain of 2 holders — while 19 added to existing stakes and 7 trimmed.

The largest buyer was Sessa Capital, opening a new position worth an estimated $1.97M. The largest seller was Deerfield Management, exiting entirely with an estimated $11.4M sold.

  • 40 institutional investors held RxSight (RXST) as of Q4 2021, up from 39 in Q3 2021.
  • Funds reported $75M of RxSight stock for Q4 2021, down 25% quarter-over-quarter.
  • 6 funds opened new RxSight positions in Q4 2021 and 4 closed out, a net change of +2 holders.
  • The largest RxSight buyer in Q4 2021 was Sessa Capital, an estimated $1.97M added.
  • The largest RxSight seller in Q4 2021 was Deerfield Management, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2021.